Heart Failure NYHA Class III
Cardiovascular·MeSH: Heart Failure
Prevalence
1800.0 / 100K
Incidence
300.0 / 100K/yr
0 drugs in development·0 companies·3 clinical trials
Frequently asked questions
How many clinical trials target Heart Failure NYHA Class III?
There are 3 clinical trials targeting Heart Failure NYHA Class III tracked by BioSniper.
What is the prevalence of Heart Failure NYHA Class III?
The estimated prevalence of Heart Failure NYHA Class III is approximately 1800.0 per 100,000 population.
Deep-dive into Heart Failure NYHA Class III
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis